Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Immucor Shares Popped: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of blood-screening systems specialist Immucor (Nasdaq: BLUD  ) surged 30% today after the company agreed to be acquired by private equity firm TGC Capital for $1.97 billion.

So what: The all-cash deal values Immucor at $27 per share and represents a 30% premium to its Friday closing price. According to Immucor Chairman Joseph Rosen, the move will allow shareholders "to realize significant, immediate value while at the same time allowing Immucor to remain well-positioned to continue pursuing growth opportunities."

Now what: When you make 30% in one morning, taking at least some dough off the table seems like the prudent thing to do. Under the terms of the agreement, Immucor may "shop" for better proposals until Aug. 15, but holding out for a dramatically better offer seems risky. After all, with high-quality rival Bio-Rad Labs (NYSE: BIO  ) now trading at a P/E discount to Immucor, you won't have to look very far to roll your bet over.

Interested in more info on Immucor? Add it to your watchlist.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1515419, ~/Articles/ArticleHandler.aspx, 10/23/2016 10:39:51 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
BLUD.DL $0.00 Down +0.00 +0.00%
Immucor, Inc. CAPS Rating: ****
BIO $163.07 Down -1.46 -0.89%
Bio-Rad Laboratori… CAPS Rating: *****